Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Nov / The Genes of the Spectrum
Genetics and epigenetics Molecular Pathology

The Genes of the Spectrum

How is current genetic research helping to map a fuller picture of the autism spectrum?

By George Francis Lee 11/10/2022 News 2 min read

Share

The role that genetics plays in autism spectrum disorders (ASD) has been investigated for decades, but with our understanding of autism – and neurodivergence as a whole – constantly evolving, what is the current view of genetics and its relationship to ASD?

It’s not news that some genes are associated with autism but, so far, many investigations into autism genetics have focused on variants not inherited from parents. To combat this (and to create a much more accurate picture of ASD genetic risk), one team combined both de novo and inherited variants across a wide pool of cases (1). The team used SPARK (Simons Powering Autism Research), an online platform on which individuals across the autism spectrum can offer their genetic data, giving researchers access to a total of 42,607 cases.

The large cohort of autistic individuals led to the identification of five new risk genes – NAV3, ITSN1, SCAF1, HNRNPUL2, and MARK2. The data show that autistic people who have inherited loss-of-function in the first four of these genes have lower levels of cognitive impairment comorbidities than individuals without such alterations.

Elsewhere, another team has also addressed the focus on de novo variants by exploring mutations rarely observed in non-autistic individuals (2). The team analyzed more than 60,000 cases using joint analysis of protein-truncating variants (PTVs), missense variants, and copy number variants (CNVs) – ultimately leading to the discovery of 72 ASD gene associations. De novo PTVs, damaging missense variants, and CNVs made up 57.5, 21.1, and 8.44 percent of the evidence, respectively. Meanwhile, CNVs conferred greatest relative risk.

The team also conducted meta-analysis alongside individuals who presented with developmental delay. This effort led to the identification of 373 genes associated with both ASD and developmental delay, though relative frequency of these mutations differed between groups. Interestingly, the genes associated with ASD were more enriched in maturing neurons and overlapped with schizophrenia-associated genes. What future research will focus on – and where researchers come to a roadblock – is making sense of the wide overlap between genes associated with ASD and other neurodevelopmental disorders and what pathways exist between them.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. X Zhou et al., “Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes,” Nat Genet, 54, 1305 (2022). PMID: 35982159.
  2. JM Fu et al., “Rare coding variation provides insight into the genetic architecture and phenotypic context of autism,” Nat Genet 54, 1320 (2022). PMID: 35982160.

About the Author(s)

George Francis Lee

Interested in how disease interacts with our world. Writing stories covering subjects like politics, society, and climate change.

More Articles by George Francis Lee

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.